Healthcare -
Biotechnology - NASDAQ - US
$ 14.7
4.33 %
$ 1.67 B
Market Cap
-3.88
P/E
DYN - COST OF REVENUE
Cost of Revenue DYN - Dyne Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR